Summit Hotel Properties Announces 2022 Annual Meeting of Stockholders
AUSTIN, Texas, Feb. 18, 2022 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that its 2022 Annual Meeting of Stockholders will be held Thursday, May 12, 2022, beginning at 8:00 a.m. Central Time. The meeting will be held at the Hampton Inn & Suites located at 200 San Jacinto Boulevard, Austin, Texas 78701. The meeting is open to all stockholders of record as of March 11, 2022.
About Summit Hotel Properties
Summit Hotel Properties, Inc. is a publicly-traded real estate investment trust focused on owning premium-branded hotels with efficient operating models primarily in the Upscale segment of the lodging industry. As of December 31, 2021, the Company's portfolio consisted of 74 hotels, 61 of which were wholly-owned, with a total of 11,518 guestrooms located in 23 states.
For additional information, please visit the Company's website, www.shpreit.com and follow the Company on Twitter at @SummitHotel_INN.
Oracle Hospitality today announced that it has signed an agreement with Choice Hotels International, one of the largest lodging franchisors in the world, to extend its AI-powered merchandising solution Oracle...
The following issues have been halted by CIRO
Company: Fraser Mackenzie Accelerator Corp.
TSX-Venture Symbol: FMAC.P
All Issues: Yes
Reason: Pending News
Halt Time (ET): 7:37 AM
CIRO can make a decision to impose a temporary suspension (halt) of...
The Winners Circle, an innovative rewards programme and loyalty platform for horse racing fans, is delighted to announce its partnership with Saffie Osborne, an esteemed British flat racing jockey with more than 200 race wins....
Smith Douglas Homes Corp. ("Smith Douglas" or the "Company") today announced first quarter results for the three months ended March 31, 2024.
Q1 2024 Results as compared to Q1 2023:
Net new orders increased 15% to 765
Home closings increased...
Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate...
